|
VOLUME 29: NO.5 MAY 2002
Editorials
The Psychometrics of Functional Status Questionnaires: Room for Improvement
 
F. Wolfe .........865
The Place of Juvenile Onset SpA in the Durban 1997 ILAR Classification Criteria of JIA
R. Burgos-Vargas, M. Rudwaleit, J. Sieper .........869
Articles
Activation of the Immune System and Inflammatory Activity in Relation to Markers of Atherothrombotic Disease and Atherosclerosis in RA
 
S. Wållberg-Jonsson, J. Trifunovic Cvetkovic,
K. Sundqvist, A.K. Lefvert, S. Rantapää-Dahlqvist .........875
Serum MMP-3 Levels During Treatment with Sulfasalazine or Combination of MTX and
Sulfasalazine in Patients with Early RA
M.D. Posthumus, P.C. Limburg, J. Westra,
M.A. van Leeuwen, M.H. van Rijswijk .........883
Treatment with the Angiogenesis Inhibitor
Endostatin: A Novel Therapy in RA
H. Matsuno, K. Yudoh, M. Uzuki, et al .........890
Enhanced Expression of a Peanut Agglutinin
Reactive O Linked Oligosaccharide on Fibronectins from the SF of Patients with Rheumatic Disease: Quantitation, Domain Localization, and Functional Significance
S. Carsons .........896
Rheumatoid Flat Foot and Deformity of the
First Ray
M. Bouysset, J. Tebib, E. Noel, et al .........903
Decreasing Mortality in Patients with RA: Results
from a Large Population Based Cohort in Sweden, 1964-95
L. Björnådal, E. Baecklund, L. Yin, F. Granath,
L. Klareskog, A. Ekbom .........906
The Rate and Pattern of Organ Damage in Late Onset SLE
P. Maddison, V. Farewell, D. Isenberg, et al .........913
Autoantibodies to Proteinase 3 and Myeloperoxidase
in SSc
A. Ruffatti, R.A. Sinico, A. Radice, et al .........918
Oral and Ocular Manifestations in SS
W.W.I. Kalk, K. Mansour, A. Vissink, et al .........924
Anti-TS1-RNA: Characterization of Novel Antibodies Against Sequence-Specific RNA by Random RNA Selection in Patients with SS
K. Hirokawa,Y. Takasaki, K. Takeuchi, et al .........931
Change in Final Diagnosis on Second Evaluation of Labial Minor Salivary Gland Biopsies
F.B. Vivino, I. Gala, G.A. Hermann .........938
Henoch-Schönlein Purpura and Cutaneous Leukocytoclastic Angiitis Exhibit Different
HLA-DRB1 Associations
M.M. Amoli, W. Thomson, A.H. Hajeer, et al .........945
HLA-B35 Association with Nephritis in
Henoch-Schönlein Purpura
M.M. Amoli, W. Thomson, A.H. Hajeer, et al .........948
Coding Sequence 1 and Promoter Single Nucleotide Polymorphisms in the CTLA-4 Gene in WG
R. Giscombe, X. Wang, D. Huang, A.K. Lefvert .........950
Definition of Disease Flare in AS: The Patients' Perspective
S. Brophy, A. Calin .........954
Infliximab in AS: A Prospective Observational
Inception Cohort Analysis of Efficacy and Safety
W.P. Maksymowych, G.S. Jhangri,
R.G. Lambert, et al .........959
Free HLA Class I Heavy Chain-Carrying Monocytes —
A Potential Role in the Pathogenesis of SpA
W.C. Tsai, C.J. Chen, J.H. Yen, et al .........966
MICA Rather Than MICB, TNFA, or HLA-DRB1 Is Associated with Susceptibility to PsA
S. González, J. Martínez-Borra, A. López-Vázquez,
S. García-Fernández, J.C. Torre-Alonso,
C. López-Larrea .........973
Measuring Disability in AS: Comparison of Bath AS Functional Index with Revised Leeds Disability Questionnaire
S. Eyres, A. Tennant, L. Kay,
R. Waxman, P.S. Helliwell .........979
Cardiovascular Autonomic Dysfunction in Familial Mediterranean Fever
M. Rozenbaum, J.E. Naschitz,
M. Yudashkin, et al .........987
Total Administered Dose of Ibandronate Determines Its Effects on Bone Mass and Architecture in Ovariectomized Aged Rats
F. Bauss, M. Wagner, L.H. Hothorn .........990
Trends in Medication Use for OA Treatment
J.C. Ausiello, R.S. Stafford .........999
Cost of Joint Replacement Surgery for OA: The Patients' Perspective
L. March, M. Cross, K. Tribe,
H. Lapsley, B. Courtenay, P. Brooks .........1006
Increase in Lifetime Adverse Drug Reactions, Service Utilization, and Disease Severity Among Patients Who Will Start COX-2 Specific Inhibitors: Quantitative Assessment of Channeling Bias and Confounding by Indication in 6689 Patients with RA and OA
F. Wolfe,
N. Flowers, T.A. Burke, L.M. Arguelles, D. Pettitt .........1015
The Foot Function Index with Verbal Rating Scales
(FFI-5pt): A Clinimetric Evaluation and Comparison
with the Original FFI
M.M. Kuyvenhoven, K.J. Gorter,
P. Zuithoff, E. Budiman-Mak, K.J. Conrad,
M.W.M. Post .........1023
Consultations for Work Related Low Back Pain in Argentina
E.R. Soriano, C. Zingoni, F. Lucco, L.J. Catoggio .........1029
Predictors of Success of Intervention Programs for Persons with FM
S.J. King, J. Wessel, Y. Bhambhani,
D. Sholter, W. Maksymowych .........1034
A Randomized Controlled Trial of Muscle
Strengthening versus Flexibility Training in FM
K. Dupree Jones, C.S. Burckhardt, S.R. Clark,
R.M. Bennett, K.M. Potempa .........1041
Viewpoint: Not For Sale, Not Even For Rent:
Just Say No. Thoughts About the American College
of Rheumatology Adopting a Code of Ethics
R.S. Panush .........1049
Pediatric Rheumatology
Preliminary Definition of Disease Flare in JRA
H.I. Brunner, D.J. Lovell, B.K. Finck, E.H. Giannini .........1058
Osteopenia in Adults with a History of JRA.
A Population Based Study
A.R. French, T. Mason, A.M. Nelson, et al .........1065
Differences in the Profiles of Circulating Levels of sTNFR and IL-1 Receptor Antagonist Reflect the Heterogeneity of the Subgroups of JRA
M.A. Muzaffer, J-M. Dayer, B.M. Feldman, et al .........1071
High Response Rate in the Phase I/II Study of Meloxicam in JRA
I. Foeldvari, R. Burgos-Vargas, A. Thon, D. Tuerck .........1079
An Unknown Autoinflammatory Syndrome Associated with Short Stature and Dysmorphic Features in a Young Boy
A. Mégarbané, A. Sanders, E. Chouery,
V. Delague, M. Medlej-Hashim, P-H. Torbey .........1084
Case Reports
Synovial Lipomatosis (Lipoma Arborescens) Affecting Multiple Joints in a Patient with Congenital Short
Bowel Syndrome
C. Siva, R. Brasington, W. Totty,
A. Sotelo, J. Atkinson .........1088
Mycobacterium tuberculosis Infection of a
Tophaceous Pseudogout Nodule
A.S. Santos-Ocampo, T.E. Tupasi, F. Villanueva,
F.K.A. Roxas, C.P. Ramos .........1093
Images in Rheumatology
Epitrochlear Lymphadenopathy in RA Caused by Silicone Particles
P.V. Balint, A. McEntegart,
R. Jackson, A.W. Forrester, R.G. Simpson .........1097
Lumbar Spondylodiscitis in SAPHO Syndrome: Multimodality Imaging Findings
T. Akisue,
T. Yamamoto, T. Marui, et al .........1100
Weber-Christian Disease with Severe Polyarthritis and Polyosteitis
F. Rehman, M. Harth, A.R. Spouge .........1102
Correspondence
MTX as a Possible Trigger of Macrophage Activation Syndrome in Systemic JIA
R. Eraso, A. Gedalia, L.R. Espinoza .........1104
Reply A. Ravelli, A. Martini .........1104
Macrophage Activation Syndrome Is Hemophagocytic Lymphohistiocytosis — Need for the Right Terminology
A.V. Ramanan, E.M. Baildam, R.F. Wynn .........1105
Reply A. Ravelli, A. Martini .........1105
Prevalence of SpA in Japan
E. Feldtkeller, J. Braun .........1105
Reply S. Hukuda, K. Shichikawa .........1107
Bone Involvement in PsA
B. Cortet, M-H. Trouvé, R-M. Flipo .........1107
Letter J.M. Nolla, J. Fiter, A. Rozadilla,
C. Gómez-Vaquero .........1108
Reply B. Frediani .........1109
Letters
An Open-label, Phase I/II Study of 5-Fluorouracil Plus Leucovorin in the Treatment of RA
T.W. Bunch,
C. Erlichman, H.S. Luthra, E.L. Matteson .........
1109
Bisphosphonate Addition to Stable Hormone Replacement Therapy Increases BMD in Postmenopausal Women
P. Boulos, R.J. Sebaldt, C.H. Goldsmith .........1110
Infliximab for Systemic Onset JIA: Experience in 3 Children
A.D. Billiau, F. Cornillie, C. Wouters .........1111
Book Review
Osteoarthritis: Diagnosis and Medical/Surgical Management, 3rd edition .........1114
Notices .........xiii
| 
